{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:33:59Z","timestamp":1785540839458,"version":"3.56.0"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2016,6,21]],"date-time":"2016-06-21T00:00:00Z","timestamp":1466467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["N01-A1-40072"],"award-info":[{"award-number":["N01-A1-40072"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0157335","type":"journal-article","created":{"date-parts":[[2016,6,22]],"date-time":"2016-06-22T22:54:42Z","timestamp":1466636082000},"page":"e0157335","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":67,"title":["A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN\u00ae) in 56-80-Year-Old Subjects"],"prefix":"10.1371","volume":"11","author":[{"given":"Richard N.","family":"Greenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Hay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack T.","family":"Stapleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Marbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Kreitmeir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6206-091X","authenticated-orcid":true,"given":"Siegfried","family":"R\u00f6esch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"von Krempelhuber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8559-1302","authenticated-orcid":true,"given":"Darja","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Weigl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garth","family":"Virgin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaly","family":"Arndtz-Wiedemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Chaplin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,6,21]]},"reference":[{"issue":"22","key":"ref1","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1056\/NEJM198011273032204","article-title":"The confirmation and maintenance of smallpox eradication","volume":"303","author":"JG Breman","year":"1980","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0147-9571(03)00025-0","article-title":"Smallpox vaccination and bioterrorism with pox viruses","volume":"23","author":"A Mayr","year":"2003","journal-title":"Comp Immun Microbiol Infect Dis"},{"issue":"8","key":"ref3","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1586\/14760584.7.8.1225","article-title":"Smallpox vaccines for biodefense: need and feasibility","volume":"7","author":"AW Artenstein","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJM196911272812201","article-title":"Complications of smallpox vaccination, 1968","volume":"281","author":"JM Lane","year":"1969","journal-title":"N Engl J Med"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/jama.1970.03170160031005","article-title":"Deaths attributable to smallpox vaccination, 1959 to 1966, and 1968","volume":"212","author":"JM Lane","year":"1970","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/infdis\/122.4.303","article-title":"Complications of smallpox vaccination, 1968: results of ten statewide surveys","volume":"122","author":"JM Lane","year":"1970","journal-title":"J Infect Dis"},{"issue":"52","key":"ref7","doi-asserted-by":"crossref","first-page":"7442","DOI":"10.1016\/j.vaccine.2009.05.095","article-title":"Modified vaccinia Ankara strains with identical coding sequences actually represent complex mixtures of viruses that determine the biological properties of each strain","volume":"27","author":"M Suter","year":"2009","journal-title":"Vaccine"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/infdis\/jis753","article-title":"Safety, Immunogenicity, and Surrogate Markers of Clinical Efficacy for Modified Vaccinia Ankara as a Smallpox Vaccine in HIV-Infected Subjects","volume":"207","author":"RN Greenberg","year":"2013","journal-title":"J Infect Dis"},{"key":"ref9","first-page":"1","article-title":"Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An open-Label, Controlled Clinical Phase II Trial","author":"E Overton","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"5696","DOI":"10.1016\/j.vaccine.2014.08.022","article-title":"Safety and immunogenicity of modified vaccinia ankara as a smallpox vaccine in people with atopic dermatitis","volume":"32","author":"F von Sonnenburg","year":"2014","journal-title":"Vaccine"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1093\/infdis\/jit105","article-title":"Safety and immunogenicity of modified vaccinia Ankara in hematopoietic stem cell transplant recipients: a randomized, controlled trial","volume":"207","author":"SR Walsh","year":"2013","journal-title":"JID"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"8562","DOI":"10.1016\/j.vaccine.2007.10.017","article-title":"Clinical and immunologic responses to multiple doses of IMVAMUNE (Modified Vaccinia Ankara) followed by Dryvax challenge","volume":"25","author":"SE Frey","year":"2007","journal-title":"Vaccine"},{"issue":"29","key":"ref13","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1016\/j.vaccine.2013.04.050","article-title":"Safety and immunogenicity of IMVAMUNE<sup>\u00ae<\/sup> smallpox vaccine using different strategies for a post event scenario","volume":"31","author":"S Frey","year":"2013","journal-title":"Vaccine"},{"issue":"23","key":"ref14","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1016\/j.vaccine.2014.02.043","article-title":"Phase II randomized, double-blinded comparison of a single high dose (5 x 10<sup>8<\/sup> TCID<sub>50<\/sub>) of modified vaccinia Ankara compared to a standard dose (1 x 10<sup>8<\/sup> TCID<sub>50<\/sub>) in healthy vaccinia-na\u00efve individuals","volume":"32","author":"S Frey","year":"2014","journal-title":"Vaccine"},{"key":"ref15","article-title":"Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes od administration in healthy vaccinia-na\u00efve subjects","author":"SE Frey","year":"2015","journal-title":"Vaccine"},{"issue":"4","key":"ref16","doi-asserted-by":"crossref","first-page":"e0122653","DOI":"10.1371\/journal.pone.0122653","article-title":"Cardiac Safety of Modified Vaccinia Ankara for Vaccination against Smallpox in a Young Healthy Study Population","volume":"10","author":"E Zitzmann-Roth","year":"2015","journal-title":"PLOS One"},{"issue":"10","key":"ref17","doi-asserted-by":"crossref","first-page":"e0138348","DOI":"10.1371\/journal.pone.0138348","article-title":"A multicenter, open-label, controlled phase II study to evaluate safety and immunogenicity of MVA smallpox vaccine (IMVAMUNE<sup>\u00ae<\/sup>) in 18\u201340 year old subjects with diagnosed atopic dermatitis","volume":"10","author":"RN Greenberg","year":"2015","journal-title":"PLOS One"},{"issue":"12","key":"ref18","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.vaccine.2005.11.022","article-title":"Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine","volume":"24","author":"J Vollmar","year":"2006","journal-title":"Vaccine"},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.vaccine.2009.11.030","article-title":"A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE","volume":"28(","author":"A Von Krempelhuber","year":"2010","journal-title":"Vaccine"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1172\/JCI33940","article-title":"Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protection","volume":"118","author":"C Samuelsson","year":"2008","journal-title":"J Clin Invest"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1016\/j.vaccine.2009.06.105","article-title":"Evaluation of the efficacy of modified vaccinia Ankara (MVA)\/IMVAMUNE against aerosolized rabbitpox virus in a rabbit model","volume":"27","author":"NL Garza","year":"2009","journal-title":"Vaccine"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"7845","DOI":"10.1128\/JVI.79.12.7845-7851.2005","article-title":"Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus","volume":"79","author":"KJ Stittelaar","year":"2005","journal-title":"J Virol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/path.2104","article-title":"Immunosenescence of ageing","volume":"2001","author":"AL Gruver","year":"2007","journal-title":"J Pathol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(07)60946-5","article-title":"Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial","volume":"30","author":"J Paavonen","year":"2007","journal-title":"Lancet"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1159\/000156477","article-title":"Can the Immune System Still Be Efficient in the Elderly? An Immunological and Immunoendocrine Therapeutic Perspective","volume":"15","author":"G Pfister","year":"2008","journal-title":"Neuroimmunomodulation"},{"key":"ref26","first-page":"6","article-title":"Passage history, properties, and use of attenuated vaccinia virus strain MVA","volume":"3","author":"A Mayr","year":"1975","journal-title":"Infection"},{"key":"ref27","first-page":"225","article-title":"Vaccination against pox diseases under immunosuppressive conditions","volume":"41","author":"A Mayr","year":"1978","journal-title":"Dev. Biol. Stand"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0140-6736(05)70234-8","article-title":"Safety and immunogenicity of new cell-cultured smallpox vaccine compared with calf-lymph derived vaccine: a blind, single-centre, randomized controlled trial","volume":"365","author":"RN Greenberg","year":"2005","journal-title":"Lancet"},{"key":"ref29","unstructured":"ACAM2000 Vaccines and Related Biological Products Advisory Committee (VRBPAC) Briefing Document, April 2007. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/07\/briefing\/2007-4292B2-00-index.htm\" xlink:type=\"simple\">http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/07\/briefing\/2007-4292B2-00-index.htm<\/ext-link>"},{"issue":"21","key":"ref30","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1001\/jama.294.21.2734","article-title":"Adverse events associated with Smallpox Vaccination in the United States, January-October 2003","volume":"294","author":"CG Chasey","year":"2005","journal-title":"JAMA"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/heart.83.5.596","article-title":"Epidemionolgy, aetiology, and prognosis of heart failure","volume":"83","author":"JJ McMurray","year":"2000","journal-title":"Heart"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.amjmed.2008.08.019","article-title":"Immunity from Smallpox Vaccine persists for decades: A longitudinal study","volume":"121","author":"DD Taub","year":"2008","journal-title":"Am J Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.4049\/jimmunol.171.10.4969","article-title":"Cutting edge: long-term B cell memory in humans after smallpox vaccination","volume":"171","author":"S Crotty","year":"2003","journal-title":"J Immunol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/infdis\/161.3.446","article-title":"The persistence of neutralizing antibodies after revaccination against smallpox","volume":"161","author":"B El-Ad","year":"1990","journal-title":"J Infect Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nm917","article-title":"Duration of antiviral immunity after smallpox vaccination","volume":"9","author":"E Hammarlund","year":"2003","journal-title":"Nat Med"},{"key":"ref36","unstructured":"Fenner F, Henderson DA, Arita I, Jezek Z and Ladnyi ID. Smallpox and its Eradication. World Health Organization 1988, Geneva, History of International Public Health, No. 6."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0157335","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T09:10:25Z","timestamp":1540026625000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0157335"}},"subtitle":[],"editor":[{"given":"David Joseph","family":"Diemert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,6,21]]},"references-count":36,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,6,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0157335","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,21]]}}}